scorecardresearchDivis Laboratories Share Price Live NSE, BSE, Today - Divis Laboratories

Divis Laboratories

BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 | SECTOR: Biotechnology & Drugs

4,473.60 -89.50 (-1.96%)

19 Jun 2024, 09:59 (IST)
  • Open

    4,560.35
  • High

    4,580.30
  • Low

    4,466.55
  • Prev Close

    4,563.10
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    1,187.60B
  • Volume

    6.74K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    -
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    532488
  • NSE

    DIVISLAB
  • ISIN

    INE361B01024

Divi's Laboratories Limited is an India-based company, which is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients with predominance in exports. The Company’s products include Bupropion HCl, Capecitabine, Carbidopa, Diltiazem HCl, Dextromethorphan Base, Dextromethorphan HBr, Gabapentin, Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, Olmesartan Medoxomil, Pregabalin, Ticagrelor, Triprolidine HCl, Valacyclovir HCl, Valsartan, Venlafaxine HCl and Vigabatrin. In addition to generic business, the Company, through its custom synthesis business, supports pharma companies for their patented products business right from gram scale requirements for clinical trials to launch, as well as late life cycle management. The Company’s subsidiaries include Divis Laboratories (USA) Inc. and Divi’s Laboratories Europe AG.

Company Officers

  • Kiran Divi

    Chief Executive Officer, Whole-time Director
  • L. Kishore Babu

    Chief Financial Officer
  • M. Satish Choudhury

    Compliance Officer, Company Secretary
  • Murali Divi

    Managing Director, Executive Director
  • Nilima Divi

    Whole-Time Director - (Commercial)
  • Nimmagadda Ramana

    Executive Director
  • S. Devendra Rao

    Whole-time Director (Manufacturing)